Invicta Diagnostic Limited IPO
BBSMENSEListed
Listed at
100
+17.65%
Invicta Diagnostic Limited IPO is a SME book building IPO. Issue size is 28.12 Cr. Price band is ₹80 to ₹85 per share. Minimum investment is ₹2.72 L. Lot size is 1600 shares. Open from 1 Dec 2025 to 3 Dec 2025. Allotment on 4 Dec 2025. Listing on 8 Dec 2025 at NSE. Managed by Socradamus Capital Pvt.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.
Invicta Diagnostic Limited IPO overview
Invicta Diagnostic Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Price band
₹80 to ₹85
Lot size
1600 shares / lot
Min investment
₹2,72,000
Issue open – close
1 Dec 2025 → 3 Dec 2025
Invicta Diagnostic Limited IPO important dates
Issue Opens
1 Dec 2025
Issue Closes
3 Dec 2025
Allotment
4 Dec 2025
Listing
8 Dec 2025
Invicta Diagnostic Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 3,200 | ₹2,72,000 |
| S-HNI (Min) | 3 | 4,800 | ₹4,08,000 |
| S-HNI (UPI) | 3 | 4,800 | ₹4,08,000 |
| S-HNI (Max) | 7 | 11,200 | ₹9,52,000 |
| B-HNI (Min) | 8 | 12,800 | ₹10,88,000 |
Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.
Quick Profit Calculator for Invicta Diagnostic Limited IPO
Pre-filled: Issue Price = ₹85, Lot Size = 1,600 shares, Listing Price = ₹100
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,72,000 | ₹100 | +₹48,000 |
| S-HNI (Min) | 3 | ₹4,08,000 | ₹100 | +₹72,000 |
| S-HNI (UPI) | 3 | ₹4,08,000 | ₹100 | +₹72,000 |
| S-HNI (Max) | 7 | ₹9,52,000 | ₹100 | +₹1,68,000 |
| B-HNI (Min) | 8 | ₹10,88,000 | ₹100 | +₹1,92,000 |
Profit based on the official listing price for each investor category.
About Invicta Diagnostic Limited IPO
From the company / RHP narrative.
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (PET CT, MRI)
Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic services
Three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.
The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.
Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.
As of October 31, 2025, the company employed 157 permanent employees.
Competitive Strength:
Expanding presence in the Mumbai Metropolitan Region (“MMR”), specifically in the radiology sector;
A diagnostics provider that offers a one-stop solution at an affordable price.
Technical capability and technology with IT infrastructure;
Dedicated management team with significant industry experience; and
Implementation of the Hub and Spoke Model.
Invicta Diagnostic Limited IPO Issue Objective
How the issuer plans to use IPO proceeds.
Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra; and
General Corporate purposes
Invicta Diagnostic Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.
What is Invicta Diagnostic Limited IPO?
Invicta Diagnostic Limited IPO is a public issue where the company offers its shares to investors through the stock exchange, allowing retail, HNI, and institutional participation.
What is the IPO price band of Invicta Diagnostic Limited IPO?
The IPO price band of Invicta Diagnostic Limited IPO is ₹₹80 to ₹85 per share, as mentioned in the issue details.
What is the minimum investment required for Invicta Diagnostic Limited IPO?
The minimum investment in Invicta Diagnostic Limited IPO is ₹2,72,000, based on the applicable lot size for retail investors.
What is the lot size of Invicta Diagnostic Limited IPO?
The lot size of Invicta Diagnostic Limited IPO is 1600 shares per lot, and applications must be made in multiples of this lot size.
What are the opening and closing dates of Invicta Diagnostic Limited IPO?
Invicta Diagnostic Limited IPO opens on 1 Dec 2025 and closes on 3 Dec 2025, as per the announced schedule.
What is Invicta Diagnostic Limited IPO subscription status?
Invicta Diagnostic Limited IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.
What is Invicta Diagnostic Limited IPO GMP today?
Invicta Diagnostic Limited IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.
Is Invicta Diagnostic Limited IPO GMP positive or negative?
Invicta Diagnostic Limited IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.
What does Invicta Diagnostic Limited IPO GMP indicate for listing?
A positive Invicta Diagnostic Limited IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.
When is Invicta Diagnostic Limited IPO listing date?
The expected listing date of Invicta Diagnostic Limited IPO is 8 Dec 2025, subject to completion of the allotment process.
Where can I check Invicta Diagnostic Limited IPO allotment status?
Invicta Diagnostic Limited IPO allotment status can be checked online once the allotment process is completed using application or PAN details.
Can Invicta Diagnostic Limited IPO subscription and GMP change before listing?
Yes, Invicta Diagnostic Limited IPO subscription figures and GMP may change during the issue period and before listing based on market activity.
Invicta Diagnostic Limited IPO Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Loading ratings…